Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:22 PM
Ignite Modification Date:
2025-12-24 @ 4:22 PM
NCT ID:
NCT05121766
Eligibility Criteria:
Inclusion Criteria:
* Team member at Hackensack Meridian Health
* Age: 18+
* Willing to provide informed consent
* Formal diagnosis of COVID-19 via Polymerase Chain Reaction (PCR)test (if home test was done, team member must confirm via PCR test)
* Outpatient treatment only for covid-19; no hospitalization (most team members will be vaccinated and may likely have milder case)
* Must be experiencing 1+ ongoing covid-19 symptom being measured in this study (respiratory symptoms (shortness of breath, cough), fatigue, loss of taste, loss of smell)
* Symptom(s) have persisted for more than 12 weeks after initial infection
* Symptom(s) coincided with covid-19 infection and were not present prior to covid-19 infection
* Does not have soy allergy
* Does not have allergy to fish
* Able to participate in bi-weekly surveys in Research Electronic Data Capture (REDCap)
* Able to take own blood pressure and record it in bi-weekly REDCap survey
* Willing to participate in 12-week study and be assigned to either intervention or placebo arm
* Not currently taking an omega-3 supplement or other high-dose supplement (over 2,000 IU) with potential for aiding recovery of long covid syndrome (e.g. zinc, Vit C, Elderberry).
* Able to take/swallow six mini-pills daily
* Able and willing to give a spot blood sample (2 drops) at baseline and end of study.
Exclusion Criteria:
* Not a Team Member at Hackensack Meridian Health
* Not age 18+
* Unwilling to provide informed consent/ declined to take part
* No formal diagnosis of COVID-19 via PCR test (if home test was done, team member must confirm via PCR test)
* Were hospitalized for treatment of covid-19
* Not experiencing 1+ ongoing covid-19 symptom being measured in this study (respiratory symptoms (shortness of breath, cough), fatigue, loss of taste, loss of smell)
* Symptom(s) have persisted for more than 12 weeks after initial infection
* Symptom(s) did not coincide with covid-19 infection and were present prior to covid-19 infection
* Does have soy allergy
* Does have allergy to fish
* Not able to participate in bi-weekly surveys in REDCap
* Able to take own blood pressure and record it in bi-weekly REDCap survey
* Not willing to participate in 12-week study and be assigned to either intervention or placebo arm
* Currently taking an omega-3 supplement or other high-dose supplement (over 2,000 IU) with potential for aiding recovery of long covid syndrome (e.g. zinc, Vit C, Elderberry).
* Unable to take/swallow six mini-pills daily
* Not able and not willing to give a spot blood sample (2 drops) at baseline and end of study.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
89 Years
Study:
NCT05121766
Study Brief:
Protocol Section:
NCT05121766